<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">74040</article-id><article-id pub-id-type="doi">10.7554/eLife.74040</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group></article-categories><title-group><article-title>µ-Theraphotoxin-Pn3a inhibition of Ca<sub>V</sub>3.3 channels reveals a novel isoform-selective drug binding site</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-114411"><name><surname>McArthur</surname><given-names>Jeffrey R</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2546-7913</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-255310"><name><surname>Wen</surname><given-names>Jierong</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-255311"><name><surname>Hung</surname><given-names>Andrew</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-209341"><name><surname>Finol-Urdaneta</surname><given-names>Rocio K</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2157-4532</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219125"><name><surname>Adams</surname><given-names>David J</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7030-2288</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Illawarra Health and Medical Research Institute</institution>, <institution>University of Wollongong</institution>, <addr-line><named-content content-type="city">Wollongong</named-content></addr-line>, <country>Australia</country></aff><aff id="aff2"><institution content-type="dept">School of Science</institution>, <institution>RMIT University</institution>, <addr-line><named-content content-type="city">Melbourne</named-content></addr-line>, <country>Australia</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-90985"><name><surname>Colecraft</surname><given-names>Henry M</given-names></name><role>Reviewing editor</role><aff><institution>Columbia University</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>jeffreym@uow.edu.au</email> (JM);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>20</day><month>07</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e74040</elocation-id><history><date date-type="received"><day>20</day><month>09</month><year>2021</year></date><date date-type="accepted"><day>19</day><month>07</month><year>2022</year></date></history><permissions><copyright-statement>© 2022, McArthur et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>McArthur et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-74040-v1.pdf"/><abstract><p>Low voltage-activated calcium currents are mediated by T-type calcium channels Ca<sub>V</sub>3.1, Ca<sub>V</sub>3.2, and Ca<sub>V</sub>3.3, which modulate a variety of physiological processes including sleep, cardiac pace-making, pain, and epilepsy. Ca<sub>V</sub>3 isoforms' biophysical properties, overlapping expression, and lack of subtype-selective pharmacology hinder the determination of their specific physiological roles in health and disease. We have identified μ-theraphotoxin Pn3a as the first subtype-selective spider venom peptide inhibitor of Ca<sub>V</sub>3.3, with &gt;100-fold lower potency against the other T-type isoforms. Pn3a modifies Ca<sub>V</sub>3.3 gating through a depolarizing shift in the voltage dependence of activation thus decreasing Ca<sub>V</sub>3.3-mediated currents in the normal range of activation potentials. Paddle chimeras of K<sub>V</sub>1.7 channels bearing voltage sensor sequences from all four Ca<sub>V</sub>3.3 domains revealed preferential binding of Pn3a to the S3-S4 region of domain II (Ca<sub>V</sub>3.3<sup>DII</sup>). This novel T-type channel pharmacological site was explored through computational docking simulations of Pn3a, site-directed mutagenesis, and full domain II swaps between Cav3 channels highlighting it as a subtype-specific pharmacophore. This research expands our understanding of T-type calcium channel pharmacology and supports the suitability of Pn3a as a molecular tool in the study of the physiological roles of Ca<sub>V</sub>3.3 channels.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001061</institution-id><institution>Rebecca L. Cooper Medical Research Foundation</institution></institution-wrap></funding-source><award-id>PG2019396</award-id><principal-award-recipient><name><surname>McArthur</surname><given-names>Jeffrey R</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000925</institution-id><institution>National Health and Medical Research Council</institution></institution-wrap></funding-source><award-id>APP1072113</award-id><principal-award-recipient><name><surname>Adams</surname><given-names>David J</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting file</p></sec><supplementary-material><ext-link xlink:href="elife-74040-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>